Airfinity forecasting platform
Forecasts for Respiratory ID
See how respiratory disease will evolve — before it happens.
FRIDA™ delivers accurate, real-time forecasts of infectious disease dynamics across key respiratory pathogens. Built on backtested epidemiological models and Airfinity’s global data infrastructure, it gives teams clear short- and medium-term visibility into disease spread.
Respiratory disease dynamics
Live forecast
Forecast
Short + medium term
Markets
Global coverage
Diseases
Influenza, RSV, hMPV, COVID-19, ILI, ARI & SARI
Respiratory markets shift quickly across seasons and geographies.
Teams rely on static, fragmented data that is quickly outdated.
Missed demand signals lead to inefficiencies and reactive planning.
FRIDA combines global epidemiological data with advanced modelling to deliver accurate, granular forecasts that update as new signals emerge.
Track how influenza, COVID-19, hMPV, and RSV are expected to evolve across key markets.
Understand how respiratory disease waves overlap and interact over time.
Interrogate disease dynamics, model assumptions and underlying data with an AI-powered layer.
Back-test your sales data, determine the impact of respiratory disease waves and forecast sales more accurately.
FRIDA helps commercial, clinical, supply chain and public health teams move earlier, reduce uncertainty and make better-informed decisions before respiratory disease peaks.
Better disease forecasts increase the impact of your vaccines — and help save lives.
The challenge
Campaigns are not aligned with disease transmission, inventory is mismatched to demand and clinical trials become more expensive when disease timing shifts unexpectedly.
Improve campaign timing, maximise uptake and strengthen the health economics case for vaccines.
Align production capacity and logistics to real seasonal demand signals.
Use forecasts to optimise site selection and accelerate patient recruitment.
Deploy earlier and target markets with greater confidence.
FRIDA helps respiratory treatment producers improve forecasting across production, supply and commercial planning.
The challenge
Demand signals arrive too late, season forecasts lag reality and commercial teams lack reliable leading indicators.
Align production capacity and logistics to actual season timing and severity.
Deploy marketing and sales activity earlier and with greater confidence.
Identify which disease metrics best predict product demand.
Reduce costly oversupply and avoid shortages during severe seasons.
Anticipate testing demand before it peaks and align supply, sales and distribution accordingly.
The challenge
Testing demand is reactive, inventory mismatches create waste and commercial activity often deploys too late.
See where and when respiratory disease is expected to peak.
Model multiple demand scenarios to reduce overstocking and shortages.
Time affiliate and in-market activity ahead of disease peaks.
Identify which metrics best predict testing demand across markets.
From hospital capacity planning to vaccination timing — make earlier, better-informed decisions.
The challenge
Hospital surges arrive quickly, campaigns launch too late and antiviral stockpiles are difficult to calibrate accurately.
Forecast admissions earlier to improve staffing and ICU readiness.
Launch campaigns ahead of peak transmission windows.
Calibrate antiviral procurement to expected season severity.
Track seven respiratory pathogens simultaneously across markets.
FRIDA delivers detailed forecasts across major respiratory disease markets, with expanding regional and local coverage. 15 largest markets covered and more countries can be added on request.
Symptomatic case forecasts across key markets.
Disease dynamics, hospitalisations and deaths where available.
Forward-looking insight into seasonal burden and market demand.
Expanding visibility into emerging respiratory disease dynamics.
Track broader respiratory illness trends to contextualise disease activity.
FRIDA is built on over a decade of infectious disease expertise, proprietary data streams and continuously refined forecasting models.
FRIDA leverages Airfinity’s structured global data infrastructure to provide a more complete and continuously updated view of respiratory disease dynamics.
Our models have been developed over years and tested against advanced internal approaches, giving teams confidence in the forecasts they use to plan.
FRIDA gives teams the clarity they need to stay ahead of respiratory disease dynamics — and the confidence to act on it.
Enterprise-grade security
Flexible integrations
Fast onboarding
Tell us about your team and we’ll tailor a FRIDA walkthrough.